Literature DB >> 19632199

Heparin-induced circular dichroism of chloroquine.

F E Stanley1, A M Warner, S M Gutierrez, A M Stalcup.   

Abstract

Circular dichroism (CD) and UV/Visible absorption (UV/Vis) spectroscopy techniques were used to investigate the interaction between heparin and chloroquine, an antimalarial drug that has shown potential as an anti-prion agent. CD spectra of rac-chloroquine upon addition of heparin provide evidence of glycosaminoglycan (GAG) binding, support recent findings suggesting that interactions between heparin and antimalarial drugs are largely due to electrostatic interactions, and represent the first reported GAG-induced CD signal of a bicyclic, aromatic compound. The association constant ( approximately 10(3)M(-1)) between chloroquine and heparin was calculated from a UV titration curve and provided additional insight into the nature of the association between these two compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632199      PMCID: PMC2752636          DOI: 10.1016/j.bbrc.2009.07.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Binding of anti-prion agents to glycosaminoglycans: evidence from electronic absorption and circular dichroism spectroscopy.

Authors:  Ferenc Zsila; Gábor Gedeon
Journal:  Biochem Biophys Res Commun       Date:  2006-06-14       Impact factor: 3.575

2.  Spectroscopic properties of complexes of acridine orange with glycosaminoglycans. I. Soluble complexes.

Authors:  M K Salter; W B Rippon; E W Abrahamson
Journal:  Biopolymers       Date:  1976-06       Impact factor: 2.505

3.  Porphyrin and phthalocyanine antiscrapie compounds.

Authors:  S A Priola; A Raines; W S Caughey
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

4.  Anomalous rotatory dispersion of metachromatic mucopolysaccharide-dye complexes. II. Heparin-methylene blue complexes at acidic pH.

Authors:  A L Stone; H Moss
Journal:  Biochim Biophys Acta       Date:  1967-02-07

5.  Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Authors:  C Korth; B C May; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.

Authors:  F L Heppner; C Musahl; I Arrighi; M A Klein; T Rülicke; B Oesch; R M Zinkernagel; U Kalinke; A Aguzzi
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

Review 7.  Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.

Authors:  Javier Díaz-Nido; Francisco Wandosell; Jesús Avila
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

Review 8.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

9.  Cell-surface prion protein interacts with glycosaminoglycans.

Authors:  Tao Pan; Boon-Seng Wong; Tong Liu; Ruliang Li; Robert B Petersen; Man-Sun Sy
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

10.  Spectroscopic studies on the spontaneous assembly of phenosafranin on glycosaminoglycans templates.

Authors:  Shuzhen Zhang; Fenglin Zhao; Na Li; Ke'an Li; Shenyang Tong
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2002-10       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.